|
1
|
American Diabetes Association. Diagnosis
and classification of diabetes mellitus. Diabetes Care. 37 (Suppl
1):S81–S90. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Atkinson MA, Eisenbarth GS and Michels AW:
Type 1 diabetes. Lancet. 383:69–82. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Henning RJ: Type-2 diabetes mellitus and
cardiovascular disease. Future Cardiol. 14:491–509. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chaudhury A, Duvoor C, Reddy Dendi VS,
Kraleti S, Chada A, Ravilla R, Marco A, Shekhawat NS, Montales MT,
Kuriakose K, et al: Clinical review of antidiabetic drugs:
implications for type 2 diabetes mellitus management. Front
Endocrinol (Lausanne). 8(6)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lamb RE and Goldstein BJ: Modulating an
oxidative-inflammatory cascade: Potential new treatment strategy
for improving glucose metabolism, insulin resistance, and vascular
function. Int J Clin Pract. 62:1087–1095. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Victor VM, Rocha M, Herance R and
Hernandez-Mijares A: Oxidative stress and mitochondrial dysfunction
in type 2 diabetes. Curr Pharm Des. 17:3947–3958. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Brownlee M: The pathobiology of diabetic
complications: A unifying mechanism. Diabetes. 54:1615–1625.
2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Asmat U, Abad K and Ismail K: Diabetes
mellitus and oxidative stress-A concise review. Saudi Pharm J.
24:547–553. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mastrocola R, Restivo F, Vercellinatto I,
Danni O, Brignardello E, Aragno M and Boccuzzi G: Oxidative and
nitrosative stress in brain mitochondria of diabetic rats. J
Endocrinol. 187:37–44. 2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Robertson RP: Chronic oxidative stress as
a central mechanism for glucose toxicity in pancreatic islet beta
cells in diabetes. J Biol Chem. 279:42351–42354. 2004.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ito T, Yoshikawa N, Ito H and Schaffer SW:
Impact of taurine depletion on glucose control and insulin
secretion in mice. J Pharmacol Sci. 129:59–64. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dokshina GA, Silaeva TIu and Lartsev EI:
Insulin-like effects of taurine. Vopr Med Khim. 22:503–507.
1976.PubMed/NCBI(In Russian).
|
|
13
|
Elizarova EP and Nedosugova LV: First
Experiments in Taurine Administration for Diabetes Mellitus. In:
Taurine 2. Huxtable RJ, Azuma J, Kuriyama K, Nakagawa M and Baba A
(eds). Springer, Boston, MA, pp583-588, 1996.
|
|
14
|
Damasceno DC, Netto AO, Iessi IL, Gallego
FQ, Corvino SB, Dallaqua B, Sinzato YK, Bueno A, Calderon IM and
Rudge MV: Streptozotocin-induced diabetes models:
Pathophysiological mechanisms and fetal outcomes. BioMed Res Int.
2014(819065)2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lenzen S: The mechanisms of alloxan- and
streptozotocin-induced diabetes. Diabetologia. 51:216–226.
2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Szkudelski T: The mechanism of alloxan and
streptozotocin action in B cells of the rat pancreas. Physiol Res.
50:537–546. 2001.PubMed/NCBI
|
|
17
|
Sandler S and Swenne I: Streptozotocin,
but not alloxan, induces DNA repair synthesis in mouse pancreatic
islets in vitro. Diabetologia. 25:444–447. 1983.PubMed/NCBI View Article : Google Scholar
|
|
18
|
El-Batch M, Hassan AM and Mahmoud HA:
Taurine is more effective than melatonin on cytochrome P450 2E1 and
some oxidative stress markers in streptozotocin-induced diabetic
rats. J Agric Food Chem. 59:4995–5000. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hansen SH: The role of taurine in diabetes
and the development of diabetic complications. Diabetes Metab Res
Rev. 17:330–346. 2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Das J, Vasan V and Sil PC: Taurine exerts
hypoglycemic effect in alloxan-induced diabetic rats, improves
insulin-mediated glucose transport signaling pathway in heart and
ameliorates cardiac oxidative stress and apoptosis. Toxicol Appl
Pharmacol. 258:296–308. 2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Gavrovskaya LK, Ryzhova OV, Safonova AF,
Matveev AK and Sapronov NS: Protective effect of taurine on rats
with experimental insulin-dependent diabetes mellitus. Bull Exp
Biol Med. 146:226–228. 2008.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Winiarska K, Szymanski K, Gorniak P,
Dudziak M and Bryla J: Hypoglycaemic, antioxidative and
nephroprotective effects of taurine in alloxan diabetic rabbits.
Biochimie. 91:261–270. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Budhram R, Pandya KG and Lau-Cam CA:
Protection by Taurine and Thiotaurine Against Biochemical and
Cellular Alterations Induced by Diabetes in a Rat Model. In:
Taurine 8. El Idrissi A and L'Amoreaux WJ (eds). Springer, New
York, NY, pp321-343, 2013.
|
|
24
|
Pandya KG, Budhram R, Clark G and Lau-Cam
CA: Comparative Evaluation of Taurine and Thiotaurine as
Protectants Against Diabetes-Induced Nephropathy in a Rat Model.
In: Taurine 8. El Idrissi A and L'Amoreaux WJ (eds). Springer, New
York, NY, pp371-394, 2013.
|
|
25
|
Alvarado-Vásquez N, Zamudio P, Cerón E,
Vanda B, Zenteno E and Carvajal-Sandoval G: Effect of glycine in
streptozotocin-induced diabetic rats. Comp Biochem Physiol C
Toxicol Pharmacol. 134:521–527. 2003.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Goodman HO and Shihabi ZK: Supplemental
taurine in diabetic rats: Effects on plasma glucose and
triglycerides. Biochem Med Metab Biol. 43:1–9. 1990.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Di Leo MAS, Santini SA, Silveri NG,
Giardina B, Franconi F and Ghirlanda G: Long-term taurine
supplementation reduces mortality rate in streptozotocin-induced
diabetic rats. Amino Acids. 27:187–191. 2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Abebe W: Effects of taurine on the
reactivity of aortas from diabetic rats. Life Sci. 82:279–289.
2008.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ulrich-Merzenich G, Zeitler H, Vetter H
and Bhonde RR: Protective effects of taurine on endothelial cells
impaired by high glucose and oxidized low density lipoproteins. Eur
J Nutr. 46:431–438. 2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang CF, Yuan JR, Qin D, Gu JF, Zhao BJ,
Zhang L, Zhao D, Chen J, Hou XF, Yang N, et al: Protection of
tauroursodeoxycholic acid on high glucose-induced human retinal
microvascular endothelial cells dysfunction and
streptozotocin-induced diabetic retinopathy rats. J Ethnopharmacol.
185:162–170. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ogasawara M, Nakamura T, Koyama I, Nemoto
M and Yoshida T: Reactivity of taurine with aldehydes and its
physiological role. Chem Pharm Bull (Tokyo). 41:2172–2175.
1993.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Casey RG, Gang C, Joyce M and
Bouchier-Hayes DJ: Taurine attenuates acute hyperglycaemia-induced
endothelial cell apoptosis, leucocyte-endothelial cell interactions
and cardiac dysfunction. J Vasc Res. 44:31–39. 2007.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wang LJ, Yu YH, Zhang LG, Wang Y, Niu N,
Li Q and Guo LM: Taurine rescues vascular endothelial dysfunction
in streptozocin-induced diabetic rats: Correlated with
downregulation of LOX-1 and ICAM-1 expression on aortas. Eur J
Pharmacol. 597:75–80. 2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Mochizuki H, Takido J and Yokogoshi H:
Effect of dietary taurine on endogenous hypercholesterolemia in
rats fed on phenobarbital-containing diets. Biosci Biotechnol
Biochem. 63:1298–1300. 1999.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mohamed NA and Gawad HSA: Taurine dietary
supplementation attenuates brain, thyroid, testicular disturbances
and oxidative stress in streptozotocin-induced diabetes mellitus in
male rats. Beni Suef Univ J Basic Appl Sci. 6:247–252. 2017.
|
|
36
|
Lieber CS: Cytochrome P-4502E1: Its
physiological and pathological role. Physiol Rev. 77:517–544.
1997.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Fukuda N, Yoshitama A, Sugita S, Fujita M
and Murakami S: Dietary taurine reduces hepatic secretion of
cholesteryl ester and enhances fatty acid oxidation in rats fed a
high-cholesterol diet. J Nutr Sci Vitaminol (Tokyo). 57:144–149.
2011.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Rashid K, Das J and Sil PC: Taurine
ameliorate alloxan induced oxidative stress and intrinsic apoptotic
pathway in the hepatic tissue of diabetic rats. Food Chem Toxicol.
51:317–329. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Patel SN and Lau-Cam CA: The Effect of
Taurine and Its Immediate Homologs on Diabetes-Induced Oxidative
Stress in the Brain and Spinal Cord of Rats. In: Taurine 10. Lee
DH, Schaffer SW, Park E and Kim HW (eds). Springer, Dordrecht,
pp337-351, 2017.
|
|
40
|
Acharya M and Lau-Cam CA: Comparison of
the protective actions of N-acetylcysteine, hypotaurine and taurine
against acetaminophen-induced hepatotoxicity in the rat. J Biomed
Sci. 17 (Suppl 1)(S35)2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Furfaro AL, Nitti M, Marengo B,
Domenicotti C, Cottalasso D, Marinari UM, Pronzato MA and Traverso
N: Impaired synthesis contributes to diabetes-induced decrease in
liver glutathione. Int J Mol Med. 29:899–905. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Aydın AF, Çoban J, Doğan-Ekici I,
Betül-Kalaz E, Doğru-Abbasoğlu S and Uysal M: Carnosine and taurine
treatments diminished brain oxidative stress and apoptosis in
D-galactose aging model. Metab Brain Dis. 31:337–345.
2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Arany E, Strutt B, Romanus P, Remacle C,
Reusens B and Hill DJ: Taurine supplement in early life altered
islet morphology, decreased insulitis and delayed the onset of
diabetes in non-obese diabetic mice. Diabetologia. 47:1831–1837.
2004.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Pandya KG, Budhram R, Clark G and Lau-Cam
CA: Comparative evaluation of taurine and thiotaurine as
protectants against diabetes-induced nephropathy in a rat model.
Adv Exp Med Biol. 775:371–394. 2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Batista TM, Ribeiro RA, Amaral AG, de
Oliveira CAM, Boschero AC and Carneiro EM: Taurine supplementation
restores glucose and carbachol-induced insulin secretion in islets
from low-protein diet rats: Involvement of Ach-M3R, Synt 1 and
SNAP-25 proteins. J Nutr Biochem. 23:306–312. 2012.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Vettorazzi JF, Ribeiro RA, Santos-Silva
JC, Borck PC, Batista TM, Nardelli TR, Boschero AC and Carneiro EM:
Taurine supplementation increases K(ATP) channel protein content,
improving Ca2+ handling and insulin secretion in islets from
malnourished mice fed on a high-fat diet. Amino Acids.
46:2123–2136. 2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Lin S, Wu G, Zhao D, Han J, Yang Q, Feng
Y, Liu M, Yang J and Hu J: Taurine increases insulin expression in
STZ-treated rat islet cells in vitro. Adv Exp Med Biol.
975:319–328. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Carneiro EM, Latorraca MQ, Araujo E,
Beltrá M, Oliveras MJ, Navarro M, Berná G, Bedoya FJ, Velloso LA
and Soria B: Taurine supplementation modulates glucose homeostasis
and islet function. J Nutr Biochem. 20:503–511. 2009.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Santos-Silva JC, Ribeiro RA, Vettorazzi
JF, Irles E, Rickli S, Borck PC, Porciuncula PM, Quesada I, Nadal
A, Boschero AC, et al: Taurine supplementation ameliorates glucose
homeostasis, prevents insulin and glucagon hypersecretion, and
controls β, α, and δ-cell masses in genetic obese mice. Amino
Acids. 47:1533–1548. 2015.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Kataoka K: Multiple mechanisms and
functions of maf transcription factors in the regulation of
tissue-specific genes. J Biochem. 141:775–781. 2007.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Kim JY, Chu K, Kim HJ, Seong HA, Park KC,
Sanyal S, Takeda J, Ha H, Shong M, Tsai MJ, et al: Orphan nuclear
receptor small heterodimer partner, a novel corepressor for a basic
helix-loop-helix transcription factor BETA2/neuroD. Mol Endocrinol.
18:776–790. 2004.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Yildirim Z and Kilic N: Effects of Taurine
and Age on Cerebellum Antioxidant Status and Oxidative Stress. Int
J Gerontol. 5:166–170. 2011.
|
|
53
|
Raza H, John A and Howarth FC: Increased
oxidative stress and mitochondrial dysfunction in zucker diabetic
rat liver and brain. Cell Physiol Biochem. 35:1241–1251.
2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
El Idrissi A and L'Amoreaux WJ: Selective
resistance of taurine-fed mice to isoniazide-potentiated seizures:
In vivo functional test for the activity of glutamic acid
decarboxylase. Neuroscience. 156:693–699. 2008.PubMed/NCBI View Article : Google Scholar
|
|
55
|
L'Amoreaux WJ, Marsillo A and El Idrissi
A: Pharmacological characterization of GABAA receptors in
taurine-fed mice. J Biomed Sci. 17 (Suppl 1)(S14)2010.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Caletti G, Almeida FB, Agnes G, Nin MS,
Barros HMT and Gomez R: Antidepressant dose of taurine increases
mRNA expression of GABAA receptor α2 subunit and BDNF in the
hippocampus of diabetic rats. Behav Brain Res. 283:11–15.
2015.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Li F, Obrosova IG, Abatan O, Tian D,
Larkin D, Stuenkel EL and Stevens MJ: Taurine replacement
attenuates hyperalgesia and abnormal calcium signaling in sensory
neurons of STZ-D rats. Am J Physiol Endocrinol Metab. 288:E29–E36.
2005.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Li F, Abatan OI, Kim H, Burnett D, Larkin
D, Obrosova IG and Stevens MJ: Taurine reverses neurological and
neurovascular deficits in Zucker diabetic fatty rats. Neurobiol
Dis. 22:669–676. 2006.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Das J, Roy A and Sil PC: Mechanism of the
protective action of taurine in toxin and drug induced organ
pathophysiology and diabetic complications: A review. Food Funct.
3:1251–1264. 2012.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Chen WQ, Jin H, Nguyen M, Carr J, Lee YJ,
Hsu CC, Faiman MD, Schloss JV and Wu JY: Role of taurine in
regulation of intracellular calcium level and neuroprotective
function in cultured neurons. J Neurosci Res. 66:612–619.
2001.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Agca CA, Tuzcu M, Hayirli A and Sahin K:
Taurine ameliorates neuropathy via regulating NF-κB and Nrf2/HO-1
signaling cascades in diabetic rats. Food Chem Toxicol. 71:116–121.
2014.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Abd El-Twab SM, Mohamed HM and Mahmoud AM:
Taurine and pioglitazone attenuate diabetes-induced testicular
damage by abrogation of oxidative stress and up-regulation of the
pituitary-gonadal axis. Can J Physiol Pharmacol. 94:651–661.
2016.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Buettner R, Schölmerich J and Bollheimer
LC: High-fat diets: Modeling the metabolic disorders of human
obesity in rodents. Obesity (Silver Spring). 15:798–808.
2007.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Schrauwen P and Hesselink MKC: Oxidative
capacity, lipotoxicity, and mitochondrial damage in type 2
diabetes. Diabetes. 53:1412–1417. 2004.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Iossa S, Mollica MP, Lionetti L, Crescenzo
R, Botta M and Liverini G: Skeletal muscle oxidative capacity in
rats fed high-fat diet. Int J Obes. 26:65–72. 2002.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Rani AJ and Mythili SV: Study on total
antioxidant status in relation to oxidative stress in type 2
diabetes mellitus. J Clin Diagn Res. 8:108–110. 2014.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Franconi F, Bennardini F, Mattana A,
Miceli M, Ciuti M, Mian M, Gironi A, Anichini R and Seghieri G:
Plasma and platelet taurine are reduced in subjects with
insulin-dependent diabetes mellitus: Effects of taurine
supplementation. Am J Clin Nutr. 61:1115–1119. 1995.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Yamori Y, Liu L, Mori M, Sagara M,
Murakami S, Nara Y and Mizushima S: Taurine as the Nutritional
Factor for the Longevity of the Japanese Revealed by a World-Wide
Epidemiological Survey. Adv Exp Med Biol. 643:13–25.
2009.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Merheb M, Daher RT, Nasrallah M, Sabra R,
Ziyadeh FN and Barada K: Taurine intestinal absorption and renal
excretion test in diabetic patients: A pilot study. Diabetes Care.
30:2652–2654. 2007.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Kim KS, Oh DH, Kim JY, Lee BG, You JS,
Chang KJ, Chung HJ, Yoo MC, Yang HI, Kang JH, et al: Taurine
ameliorates hyperglycemia and dyslipidemia by reducing insulin
resistance and leptin level in Otsuka Long-Evans Tokushima fatty
(OLETF) rats with long-term diabetes. Exp Mol Med. 44:665–673.
2012.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Harada H, Tsujino T, Watari Y, Nonaka H,
Emoto N and Yokoyama M: Oral taurine supplementation prevents
fructose-induced hypertension in rats. Heart Vessels. 19:132–136.
2004.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Chauncey KB, Tenner TE Jr, Lombardini JB,
Jones BG, Brooks ML, Warner RD, Davis RL and Ragain RM: The effect
of taurine supplementation on patients with type 2 diabetes
mellitus. Adv Exp Med Biol. 526:91–96. 2003.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Xiao C, Giacca A and Lewis GF: Oral
taurine but not N-acetylcysteine ameliorates NEFA-induced
impairment in insulin sensitivity and beta cell function in obese
and overweight, non-diabetic men. Diabetologia. 51:139–146.
2008.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Nakaya Y, Minami A, Harada N, Sakamoto S,
Niwa Y and Ohnaka M: Taurine improves insulin sensitivity in the
Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type
2 diabetes. Am J Clin Nutr. 71:54–58. 2000.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Parvez S, Tabassum H, Banerjee BD and
Raisuddin S: Taurine prevents tamoxifen-induced mitochondrial
oxidative damage in mice. Basic Clin Pharmacol Toxicol.
102:382–387. 2008.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Liu Y and Quinn MR: Chemokine production
by rat alveolar macrophages is inhibited by taurine chloramine.
Immunol Lett. 80:27–32. 2002.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Barua M, Liu Y and Quinn MR: Taurine
chloramine inhibits inducible nitric oxide synthase and TNF-alpha
gene expression in activated alveolar macrophages: decreased
NF-kappaB activation and IkappaB kinase activity. J Immunol.
167:2275–2281. 2001.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Camargo RL, Batista TM, Ribeiro RA,
Velloso LA, Boschero AC and Carneiro EM: Effects of Taurine
Supplementation Upon Food Intake and Central Insulin Signaling in
Malnourished Mice Fed on a High-Fat Diet. In: Taurine 8. El Idrissi
A and L'Amoreaux WJ (eds). Springer, New York, NY, pp93-103,
2013.
|
|
79
|
El Idrissi A and Trenkner E: Growth
factors and taurine protect against excitotoxicity by stabilizing
calcium homeostasis and energy metabolism. J Neurosci.
19:9459–9468. 1999.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Oprescu AI, Bikopoulos G, Naassan A,
Allister EM, Tang C, Park E, Uchino H, Lewis GF, Fantus IG,
Rozakis-Adcock M, et al: Free fatty acid-induced reduction in
glucose-stimulated insulin secretion: Evidence for a role of
oxidative stress in vitro and in vivo. Diabetes. 56:2927–2937.
2007.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Jong CJ, Azuma J and Schaffer S: Mechanism
underlying the antioxidant activity of taurine: Prevention of
mitochondrial oxidant production. Amino Acids. 42:2223–2232.
2012.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Suzuki T, Suzuki T, Wada T, Saigo K and
Watanabe K: Taurine as a constituent of mitochondrial tRNAs: New
insights into the functions of taurine and human mitochondrial
diseases. EMBO J. 21:6581–6589. 2002.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Kirino Y, Yasukawa T, Ohta S, Akira S,
Ishihara K, Watanabe K and Suzuki T: Codon-specific translational
defect caused by a wobble modification deficiency in mutant tRNA
from a human mitochondrial disease. Proc Natl Acad Sci USA.
101:15070–15075. 2004.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Krauss S, Zhang CY, Scorrano L, Dalgaard
LT, St-Pierre J, Grey ST and Lowell BB: Superoxide-mediated
activation of uncoupling protein 2 causes pancreatic β cell
dysfunction. J Clin Invest. 112:1831–1842. 2003.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Kondo Y, Toda Y, Kitajima H, Oda H, Nagate
T, Kameo K and Murakami S: Taurine inhibits development of
atherosclerotic lesions in apolipoprotein E-deficient mice. Clin
Exp Pharmacol Physiol. 28:809–815. 2001.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Murakami S, Kondo Y, Sakurai T, Kitajima H
and Nagate T: Taurine suppresses development of atherosclerosis in
Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis.
163:79–87. 2002.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Cappelli AP, Zoppi CC, Barbosa-Sampaio HC,
Costa JM Jr, Protzek AO, Morato PN, Boschero AC and Carneiro EM:
Taurine-induced insulin signalling improvement of obese
malnourished mice is associated with redox balance and protein
phosphatases activity modulation. Liver Int. 34:771–783.
2014.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Haber CA, Lam TKT, Yu Z, Gupta N, Goh T,
Bogdanovic E, Giacca A and Fantus IG: N-acetylcysteine and taurine
prevent hyperglycemia-induced insulin resistance in vivo: Possible
role of oxidative stress. Am J Physiol Endocrinol Metab.
285:E744–E753. 2003.PubMed/NCBI View Article : Google Scholar
|
|
89
|
González-Chávez A, Elizondo-Argueta S,
Gutiérrez-Reyes G and León-Pedroza JI: Pathophysiological
implications between chronic inflammation and the development of
diabetes and obesity. Cir Cir. 79:209–216. 2011.PubMed/NCBI
|
|
90
|
You JS, Zhao X, Kim SH and Chang KJ:
Positive Correlation Between Serum Taurine and Adiponectin Levels
in High-Fat Diet-Induced Obesity Rats. In: Taurine 8. El Idrissi A
and L'Amoreaux WJ (eds). Springer, New York, NY, pp105-111,
2013.
|
|
91
|
Wu N, Lu Y, He B, Zhang Y, Lin J, Zhao S,
Zhang W, Li Y and Han P: Taurine prevents free fatty acid-induced
hepatic insulin resistance in association with inhibiting JNK1
activation and improving insulin signaling in vivo. Diabetes Res
Clin Pract. 90:288–296. 2010.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Rosa FT, Freitas EC, Deminice R, Jordão AA
and Marchini JS: Oxidative stress and inflammation in obesity after
taurine supplementation: A double-blind, placebo-controlled study.
Eur J Nutr. 53:823–830. 2014.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Lim JG, Lee HY, Yun JE, Kim SP, Park JW,
Suh SI, Jang BC, Cho CH, Bae JH, Kim SS, et al: Taurine block of
cloned ATP-sensitive K+ channels with different sulfonylurea
receptor subunits expressed in Xenopus laevis oocytes. Biochem
Pharmacol. 68:901–910. 2004.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Park EJ, Bae JH, Kim SY, Lim JG, Baek WK,
Kwon TK, Suh SI, Park JW, Lee IK, Ashcroft FM, et al: Inhibition of
ATP-sensitive K+ channels by taurine through a benzamido-binding
site on sulfonylurea receptor 1. Biochem Pharmacol. 67:1089–1096.
2004.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Koh JH, Lee ES, Hyun M, Kim HM, Choi YJ,
Lee EY, Yadav D and Chung CH: Taurine alleviates the progression of
diabetic nephropathy in type 2 diabetic rat model. Int J
Endocrinol. 2014(397307)2014.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Thadani JM, Marathe A, Vakodikar S,
Kshatriya P, Modi D and Vyas R: Treatment of Type I Diabetes using
Autologous Adipose Derived Mesenchymal Stem Cells Translated to
Insulin Secreting Islet like Cell Aggregates. J Case Rep.
7:235–238. 2017.
|
|
97
|
Fujihira E, Takahashi H and Nakazawa M:
Effect of long-term feeding of taurine in hereditary hyperglycemic
obese mice. Chem Pharm Bull (Tokyo). 18:1636–1642. 1970.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Tsuboyama-Kasaoka N, Shozawa C, Sano K,
Kamei Y, Kasaoka S, Hosokawa Y and Ezaki O: Taurine
(2-aminoethanesulfonic acid) deficiency creates a vicious circle
promoting obesity. Endocrinology. 147:3276–3284. 2006.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Piña-Zentella G, de la Rosa-Cuevas G,
Vázquez-Meza H, Piña E and de Piña MZ: Taurine in adipocytes
prevents insulin-mediated H2O2 generation and
activates Pka and lipolysis. Amino Acids. 42:1927–1935.
2012.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Nardelli TR, Ribeiro RA, Balbo SL, Vanzela
EC, Carneiro EM, Boschero AC and Bonfleur ML: Taurine prevents fat
deposition and ameliorates plasma lipid profile in monosodium
glutamate-obese rats. Amino Acids. 41:901–908. 2011.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Cao PJ, Jin YJ, Li ME, Zhou R and Yang MZ:
PGC-1α may associated with the anti-obesity effect of taurine on
rats induced by arcuate nucleus lesion. Nutr Neurosci. 19:86–93.
2016.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Batista TM, Ribeiro RA, da Silva PMR,
Camargo RL, Lollo PCB, Boschero AC and Carneiro EM: Taurine
supplementation improves liver glucose control in normal protein
and malnourished mice fed a high-fat diet. Mol Nutr Food Res.
57:423–434. 2013.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Kim KS, Choi HM, Ji HI, Kim C, Kim JY,
Song R, Kim SM, Lee YA, Lee SH, Yang HI, et al: Effect of taurine
chloramine on differentiation of human preadipocytes into
adipocytes. Adv Exp Med Biol. 775:247–257. 2013.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Kim KS, Ji HI, Chung H, Kim C, Lee SH, Lee
YA, Yang HI, Yoo MC and Hong SJ: Taurine chloramine modulates the
expression of adipokines through inhibition of the STAT-3 signaling
pathway in differentiated human adipocytes. Amino Acids.
45:1415–1422. 2013.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Kim KS, You JS, Kim JY, Chang KJ, Yoo MC,
Song R, Lee YA, Lee SH, Hong SJ and Yang HI: Taurine ameliorates
hypercholesterolemia but not obesity in rats fed a lard-based,
high-fat diet. Adv Exp Med Biol. 803:271–278. 2015.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Murakami S, Nara Y and Yamori Y: Taurine
accelerates the regression of hypercholesterolemia in stroke-prone
spontaneously hypertensive rats. Life Sci. 58:1643–1651.
1996.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Chen W, Matuda K, Nishimura N and
Yokogoshi H: The effect of taurine on cholesterol degradation in
mice fed a high-cholesterol diet. Life Sci. 74:1889–1898.
2004.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Choi MJ, Kim JH and Chang KJ: The effect
of dietary taurine supplementation on plasma and liver lipid
concentrations and free amino acid concentrations in rats fed a
high-cholesterol diet. Adv Exp Med Biol. 583:235–242.
2006.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Kishida T, Miyazato S, Ogawa H and Ebihara
K: Taurine prevents hypercholesterolemia in ovariectomized rats fed
corn oil but not in those fed coconut oil. J Nutr. 133:2616–2621.
2003.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Nishimura N, Yamamoto T and Ota T: Taurine
feeding inhibits bile acid absorption from the ileum in rats fed a
high cholesterol and high fat diet. Adv Exp Med Biol. 643:285–291.
2009.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Murakami S, Kondo Y, Toda Y, Kitajima H,
Kameo K, Sakono M and Fukuda N: Effect of taurine on cholesterol
metabolism in hamsters: Up-regulation of low density lipoprotein
(LDL) receptor by taurine. Life Sci. 70:2355–2366. 2002.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Yanagita T, Han SY, Hu Y, Nagao K,
Kitajima H and Murakami S: Taurine reduces the secretion of
apolipoprotein B100 and lipids in HepG2 cells. Lipids Health Dis.
7(38)2008.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Ahmadian M, Roshan VD, Aslani E and
Stannard SR: Taurine supplementation has anti-atherogenic and
anti-inflammatory effects before and after incremental exercise in
heart failure. Ther Adv Cardiovasc Dis. 11:185–194. 2017.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Nandhini AT and Anuradha CV: Taurine
modulates kallikrein activity and glucose metabolism in insulin
resistant rats. Amino Acids. 22:27–38. 2002.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Mikami N, Hosokawa M and Miyashita K:
Dietary combination of fish oil and taurine decreases fat
accumulation and ameliorates blood glucose levels in type 2
diabetic/obese KK-A(y) mice. J Food Sci. 77:H114–H120.
2012.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Harada N, Ninomiya C, Osako Y, Morishima
M, Mawatari K, Takahashi A and Nakaya Y: Taurine alters respiratory
gas exchange and nutrient metabolism in type 2 diabetic rats. Obes
Res. 12:1077–1084. 2004.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Solon CS, Franci D, Ignacio-Souza LM,
Romanatto T, Roman EA, Arruda AP, Morari J, Torsoni AS, Carneiro EM
and Velloso LA: Taurine enhances the anorexigenic effects of
insulin in the hypothalamus of rats. Amino Acids. 42:2403–2410.
2012.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Figueroa ALC, Figueiredo H, Rebuffat SA,
Vieira E and Gomis R: Taurine Treatment Modulates Circadian Rhythms
in Mice Fed A High Fat Diet. Sci Rep. 6(36801)2016.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Ribeiro RA, Santos-Silva JC, Vettorazzi
JF, Cotrim BB, Mobiolli DDM, Boschero AC and Carneiro EM: Taurine
supplementation prevents morpho-physiological alterations in
high-fat diet mice pancreatic β-cells. Amino Acids. 43:1791–1801.
2012.PubMed/NCBI View Article : Google Scholar
|
|
120
|
McCarthy FP, Delany AC, Kenny LC and Walsh
SK: PPAR-γ - a possible drug target for complicated pregnancies. Br
J Pharmacol. 168:1074–1085. 2013.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Fujita T and Sato Y: Changes in blood
pressure and extracellular fluid with taurine in DOCA-salt rats. Am
J Physiol. 250:R1014–R1020. 1986.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Branco RC, Batista TM, Camargo RL, Borck
PC, Ribeiro RA, Zoppi CC, Lollo PC, Morato PN, Boschero AC and
Carneiro EM: Long-term taurine supplementation leads to enhanced
hepatic steatosis, renal dysfunction and hyperglycemia in mice fed
on a high-fat diet. Adv Exp Med Biol. 803:339–351. 2015.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Ware LB, Johnson ACM and Zager RA: Renal
cortical albumin gene induction and urinary albumin excretion in
response to acute kidney injury. Am J Physiol Renal Physiol.
300:F628–F638. 2011.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Declèves AE, Zolkipli Z, Satriano J, Wang
L, Nakayama T, Rogac M, Le TP, Nortier JL, Farquhar MG, Naviaux RK,
et al: Regulation of lipid accumulation by AMP-activated kinase
[corrected] in high fat diet-induced kidney injury. Kidney Int.
85:611–623. 2014.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Wang L, Zhang L, Yu Y, Wang Y and Niu N:
The protective effects of taurine against early renal injury in
STZ-induced diabetic rats, correlated with inhibition of renal
LOX-1-mediated ICAM-1 expression. Ren Fail. 30:763–771.
2008.PubMed/NCBI View Article : Google Scholar
|
|
126
|
He X, Duan Y, Yao K, Li F, Hou Y, Wu G and
Yin Y: β-Hydroxy-β-methylbutyrate, mitochondrial biogenesis, and
skeletal muscle health. Amino Acids. 48:653–664. 2016.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Tran LT, Yuen VG and McNeill JH: The
fructose-fed rat: A review on the mechanisms of fructose-induced
insulin resistance and hypertension. Mol Cell Biochem. 332:145–159.
2009.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Bantle JP, Raatz SK, Thomas W and
Georgopoulos A: Effects of dietary fructose on plasma lipids in
healthy subjects. Am J Clin Nutr. 72:1128–1134. 2000.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Nandhini ATA, Thirunavukkarasu V and
Anuradha CV: Potential role of kinins in the effects of taurine in
high-fructose-fed rats. Can J Physiol Pharmacol. 82:1–8.
2004.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Rahman MM, Park HM, Kim SJ, Go HK, Kim GB,
Hong CU, Lee YU, Kim SZ, Kim JS and Kang HS: Taurine prevents
hypertension and increases exercise capacity in rats with
fructose-induced hypertension. Am J Hypertens. 24:574–581.
2011.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Larsen LH, Orstrup LKH, Hansen SH, Grunnet
N, Quistorff B and Mortensen OH: The effect of long-term taurine
supplementation and fructose feeding on glucose and lipid
homeostasis in Wistar rats. Adv Exp Med Biol. 776:39–50.
2013.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Pilkis SJ and Granner DK: Molecular
physiology of the regulation of hepatic gluconeogenesis and
glycolysis. Annu Rev Physiol. 54:885–909. 1992.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Lau-Cam CA and Patel JP: Comparison of the
effects of taurine with those of related sulfur-containing
compounds on pyridoxal-induced adrenomedullary catecholamine
release and glycogenolysis in the rat. Adv Exp Med Biol.
583:203–212. 2006.PubMed/NCBI View Article : Google Scholar
|
|
134
|
El Mesallamy HO, El-Demerdash E, Hammad LN
and El Magdoub HM: Effect of taurine supplementation on
hyperhomocysteinemia and markers of oxidative stress in high
fructose diet induced insulin resistance. Diabetol Metab Syndr.
2(46)2010.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Devasagayam TPA, Tilak JC, Boloor KK, Sane
KS, Ghaskadbi SS and Lele RD: Free radicals and antioxidants in
human health: Current status and future prospects. J Assoc
Physicians India. 52:794–804. 2004.PubMed/NCBI
|
|
136
|
Rask-Madsen C and King GL: Mechanisms of
Disease: Endothelial dysfunction in insulin resistance and
diabetes. Nat Clin Pract Endocrinol Metab. 3:46–56. 2007.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Moloney MA, Casey RG, O'Donnell DH,
Fitzgerald P, Thompson C and Bouchier-Hayes DJ: Two weeks taurine
supplementation reverses endothelial dysfunction in young male type
1 diabetics. Diab Vasc Dis Res. 7:300–310. 2010.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Ito T, Schaffer SW and Azuma J: The
potential usefulness of taurine on diabetes mellitus and its
complications. Amino Acids. 42:1529–1539. 2012.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Fennessy FM, Moneley DS, Wang JH, Kelly CJ
and Bouchier-Hayes DJ: Taurine and vitamin C modify monocyte and
endothelial dysfunction in young smokers. Circulation. 107:410–415.
2003.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Zhang M, Bi LF, Fang JH, Su XL, Da GL,
Kuwamori T and Kagamimori S: Beneficial effects of taurine on serum
lipids in overweight or obese non-diabetic subjects. Amino Acids.
26:267–271. 2004.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Mizushima S, Nara Y, Sawamura M and Yamori
Y: Effects of Oral Taurine Supplementation on Lipids and
Sympathetic Nerve Tone. In: Taurine 2. Huxtable RJ, Azuma J,
Kuriyama K, Nakagawa M and Baba A (eds). Springer, Boston, MA,
pp615-622, 1996.
|
|
142
|
Nakamura T, Ushiyama C, Suzuki S, Shimada
N, Ohmuro H, Ebihara I and Koide H: Effects of taurine and vitamin
E on microalbuminuria, plasma metalloproteinase-9, and serum type
IV collagen concentrations in patients with diabetic nephropathy.
Nephron J. 83:361–362. 1999.PubMed/NCBI View Article : Google Scholar
|
|
143
|
Cusworth DC and Dent CE: Renal clearances
of amino acids in normal adults and in patients with aminoaciduria.
Biochem J. 74:550–561. 1960.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Mozaffari MS and Schaffer D: Taurine
modulates arginine vasopressin-mediated regulation of renal
function. J Cardiovasc Pharmacol. 37:742–750. 2001.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Burg MB: Molecular basis of osmotic
regulation. Am J Physiol. 268:F983–F996. 1995.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Gomez RA, Tufro-McReddie A, Everett AD and
Pentz ES: Ontogeny of renin and AT1 receptor in the rat. Pediatr
Nephrol. 7:635–638. 1993.PubMed/NCBI View Article : Google Scholar
|
|
147
|
Han X and Chesney RW: The role of taurine
in renal disorders. Amino Acids. 43:2249–2263. 2012.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Hagar HH, El Etter E and Arafa M: Taurine
attenuates hypertension and renal dysfunction induced by
cyclosporine A in rats. Clin Exp Pharmacol Physiol. 33:189–196.
2006.PubMed/NCBI View Article : Google Scholar
|
|
149
|
Ideishi M, Miura S, Sakai T, Sasaguri M,
Misumi Y and Arakawa K: Taurine amplifies renal kallikrein and
prevents salt-induced hypertension in Dahl rats. J Hypertens.
12:653–661. 1994.PubMed/NCBI
|
|
150
|
Dawson R Jr, Biasetti M, Messina S and
Dominy J: The cytoprotective role of taurine in exercise-induced
muscle injury. Amino Acids. 22:309–324. 2002.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Hu J, Xu X, Yang J, Wu G, Sun C and Lv Q:
Antihypertensive Effect of Taurine in Rat. In: Taurine 7. Azuma J,
Schaffer SW and Ito T (eds). Springer, New York, NY, pp75-84,
2009.
|
|
152
|
Mozaffari MS, Abdelsayed R, Patel C and
Schaffer SW: Effects of Dietary Salt and Fat on Taurine Excretion
in Healthy and Diseased Rats. In: Taurine 6. Oja SS and Saransaari
P (eds). Springer, Boston, MA, pp173-180, 2006.
|
|
153
|
Venkatesan N, Venkatesan P, Karthikeyan J
and Arumugam V: Protection by taurine against adriamycin-induced
proteinuria and hyperlipidemia in rats. Proc Soc Exp Biol Med.
215:158–164. 1997.PubMed/NCBI View Article : Google Scholar
|
|
154
|
Chesney RW, Han X and Patters AB: Taurine
and the renal system. J Biomed Sci. 17 (Suppl 1)(S4)2010.PubMed/NCBI View Article : Google Scholar
|
|
155
|
Koeners MP, Braam B, van der Giezen DM,
Goldschmeding R and Joles JA: Perinatal micronutrient supplements
ameliorate hypertension and proteinuria in adult fawn-hooded
hypertensive rats. Am J Hypertens. 23:802–808. 2010.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Hsueh WA and Wyne K:
Renin-Angiotensin-aldosterone system in diabetes and hypertension.
J Clin Hypertens (Greenwich). 13:224–237. 2011.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Takahashi K, Azuma M, Taira K, Baba A,
Yamamoto I, Schaffer SW and Azuma J: Effect of taurine on
angiotensin II-induced hypertrophy of neonatal rat cardiac cells. J
Cardiovasc Pharmacol. 30:725–730. 1997.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Azuma M, Takahashi K, Fukuda T, Ohyabu Y,
Yamamoto I, Kim S, Iwao H, Schaffer SW and Azuma J: Taurine
attenuates hypertrophy induced by angiotensin II in cultured
neonatal rat cardiac myocytes. Eur J Pharmacol. 403:181–188.
2000.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Nara Y, Yamori Y and Lovenberg W: Effect
of dietary taurine on blood pressure in spontaneously hypertensive
rats. Biochem Pharmacol. 27:2689–2692. 1978.PubMed/NCBI View Article : Google Scholar
|
|
160
|
Yamamoto J, Akabane S, Yoshimi H, Nakai M
and Ikeda M: Effects of taurine on stress-evoked hemodynamic and
plasma catecholamine changes in spontaneously hypertensive rats.
Hypertension. 7:913–922. 1985.PubMed/NCBI View Article : Google Scholar
|
|
161
|
Sato Y, Ogata E and Fujita T: Hypotensive
action of taurine in DOCA-salt rats--involvement of sympathoadrenal
inhibition and endogenous opiate. Jpn Circ J. 55:500–508.
1991.PubMed/NCBI View Article : Google Scholar
|
|
162
|
Patrick L: Lead toxicity part II: The role
of free radical damage and the use of antioxidants in the pathology
and treatment of lead toxicity. Altern Med Rev. 11:114–127.
2006.PubMed/NCBI
|
|
163
|
Roysommuti S, Suwanich A, Lerdweeraphon W,
Thaeomor A, Jirakulsomchok D and Wyss JM: Sex dependent effects of
perinatal taurine exposure on the arterial pressure control in
adult offspring. Adv Exp Med Biol. 643:135–144. 2009.PubMed/NCBI View Article : Google Scholar
|
|
164
|
Malpas SC, Ramchandra R, Guild SJ, McBryde
F and Barrett CJ: Renal sympathetic nerve activity in the
development of hypertension. Curr Hypertens Rep. 8:242–248.
2006.PubMed/NCBI View Article : Google Scholar
|
|
165
|
Hano T, Kasano M, Tomari H and Iwane N:
Taurine Suppresses Pressor Response Through the Inhibition of
Sympathetic Nerve Activity and the Improvement in Baro-Reflex
Sensitivity of Spontaneously Hypertensive Rats. In: Taurine 7.
Azuma J, SchafferSW and Ito T (eds). Springer, New York, NY,
pp57-63, 2009.
|
|
166
|
Iimura O and Shimamoto K: Salt and
Hypertension: Water-Sodium Handling in Essential Hypertension. Ann
N Y Acad Sci. 676:105–121. 1993.PubMed/NCBI View Article : Google Scholar
|
|
167
|
Sun Q, Wang B, Li Y, Sun F, Li P, Xia W,
Zhou X, Li Q, Wang X, Chen J, et al: Taurine Supplementation Lowers
Blood Pressure and Improves Vascular Function in Prehypertension:
Randomized, Double-Blind, Placebo-Controlled Study. Hypertension.
67:541–549. 2016.PubMed/NCBI View Article : Google Scholar
|
|
168
|
Katakawa M, Fukuda N, Tsunemi A, Mori M,
Maruyama T, Matsumoto T, Abe M and Yamori Y: Taurine and magnesium
supplementation enhances the function of endothelial progenitor
cells through antioxidation in healthy men and spontaneously
hypertensive rats. Hypertens Res. 39:848–856. 2016.PubMed/NCBI View Article : Google Scholar
|
|
169
|
Abebe W and Mozaffari MS: Effects of
chronic taurine treatment on reactivity of the rat aorta. Amino
Acids. 19:615–623. 2000.PubMed/NCBI View Article : Google Scholar
|
|
170
|
Dawson R Jr, Liu S, Jung B, Messina S and
Eppler B: Effects of high salt diets and taurine on the development
of hypertension in the stroke-prone spontaneously hypertensive rat.
Amino Acids. 19:643–665. 2000.PubMed/NCBI View Article : Google Scholar
|
|
171
|
Maia AR, Batista TM, Victorio JA, Clerici
SP, Delbin MA, Carneiro EM and Davel AP: Taurine supplementation
reduces blood pressure and prevents endothelial dysfunction and
oxidative stress in post-weaning protein-restricted rats. PLoS One.
9(e105851)2014.PubMed/NCBI View Article : Google Scholar
|
|
172
|
Ogawa M, Takahara A, Ishijima M and Tazaki
S: Decrease of plasma sulfur amino acids in essential hypertension.
Jpn Circ J. 49:1217–1224. 1985.PubMed/NCBI View Article : Google Scholar
|
|
173
|
Yamori Y, Taguchi T, Hamada A, Kunimasa K,
Mori H and Mori M: Taurine in health and diseases: Consistent
evidence from experimental and epidemiological studies. J Biomed
Sci. 17 (Suppl 1)(S6)2010.PubMed/NCBI View Article : Google Scholar
|
|
174
|
Yamori Y, Nara Y, Ikeda K and Mizushima S:
Is Taurine a Preventive Nutritional Factor of Cardiovascular
Diseases or Just a Biological Marker of Nutrition. In: Taurine 2.
Huxtable RJ, Azuma J, Kuriyama K, Nakagawa M and Baba A (eds).
Springer, Boston, MA, pp623-629, 1996.
|
|
175
|
Parikh CR, Coca SG, Thiessen-Philbrook H,
Shlipak MG, Koyner JL, Wang Z, Edelstein CL, Devarajan P, Patel UD,
Zappitelli M, et al: TRIBE-AKI Consortium: Postoperative biomarkers
predict acute kidney injury and poor outcomes after adult cardiac
surgery. J Am Soc Nephrol. 22:1748–1757. 2011.PubMed/NCBI View Article : Google Scholar
|
|
176
|
Flora SJS, Pande M, Bhadauria S and Kannan
GM: Combined administration of taurine and meso
2,3-dimercaptosuccinic acid in the treatment of chronic lead
intoxication in rats. Hum Exp Toxicol. 23:157–166. 2004.PubMed/NCBI View Article : Google Scholar
|
|
177
|
Bai J, Yao X, Jiang L, Zhang Q, Guan H,
Liu S, Wu W, Qiu T, Gao N, Yang L, et al: Taurine protects against
As2O3-induced autophagy in livers of rat offsprings through PPARγ
pathway. Sci Rep. 6(27733)2016.PubMed/NCBI View Article : Google Scholar
|
|
178
|
Yeh YH, Lee YT, Hsieh YL and Hwang DF:
Dietary taurine reduces zinc-induced toxicity in male Wistar rats.
J Food Sci. 76:T90–T98. 2011.PubMed/NCBI View Article : Google Scholar
|
|
179
|
Roy A, Manna P and Sil PC: Prophylactic
role of taurine on arsenic mediated oxidative renal dysfunction via
MAPKs/ NF-kappaB and mitochondria dependent pathways. Free Radic
Res. 43:995–1007. 2009.PubMed/NCBI View Article : Google Scholar
|
|
180
|
Bera AK, Rana T, Das S, Bhattacharya D,
Pan D, Bandyopadhyay S and Das SK: Mitigation of arsenic-mediated
renal oxidative stress in rat by Pleurotus florida lectin.
Hum Exp Toxicol. 30:940–951. 2011.PubMed/NCBI View Article : Google Scholar
|
|
181
|
Zheng Y, Qu H, Wang D, Li S, Zhang C and
Piao F: Protection of Taurine Against Arsenic-Induced DNA Damage of
Mice Kidneys. Adv Exp Med Biol. 975:917–927. 2017.PubMed/NCBI View Article : Google Scholar
|
|
182
|
Ahmad MK, Khan AA, Ali SN and Mahmood R:
Chemoprotective effect of taurine on potassium bromate-induced DNA
damage, DNA-protein cross-linking and oxidative stress in rat
intestine. PLoS One. 10(e0119137)2015.PubMed/NCBI View Article : Google Scholar
|
|
183
|
Das J, Ghosh J, Manna P and Sil PC:
Taurine protects acetaminophen-induced oxidative damage in mice
kidney through APAP urinary excretion and CYP2E1 inactivation.
Toxicology. 269:24–34. 2010.PubMed/NCBI View Article : Google Scholar
|
|
184
|
Eldin AAK, Shaheen AA, Abd Elgawad HM and
Shehata NI: Protective effect of taurine and quercetin against
renal dysfunction associated with the combined use of gentamycin
and diclofenac. Indian J Biochem Biophys. 45:332–340.
2008.PubMed/NCBI
|
|
185
|
Ma N, Kato T, Isogai T, Gu Y and Yamashita
T: The Potential Effects of Taurine in Mitigation of Radiation
Nephropathy. In: Taurine 11. Hu J, Piao F, Schaffer SW, El Idrissi
A and Wu JY (eds). Springer Singapore, Singapore, pp497-505,
2019.
|
|
186
|
Ogino T, Than TA, Hosako M, Ozaki M, Omori
M and Okada S: Taurine chloramine: A possible oxidant reservoir.
Adv Exp Med Biol. 643:451–461. 2009.PubMed/NCBI View Article : Google Scholar
|
|
187
|
Kim C and Cha YN: Production of reactive
oxygen and nitrogen species in phagocytes is regulated by taurine
chloramine. Adv Exp Med Biol. 643:463–472. 2009.PubMed/NCBI View Article : Google Scholar
|
|
188
|
Trachtman H, Futterweit S, Prenner J and
Hanon S: Antioxidants reverse the antiproliferative effect of high
glucose and advanced glycosylation end products in cultured rat
mesangial cells. Biochem Biophys Res Commun. 199:346–352.
1994.PubMed/NCBI View Article : Google Scholar
|
|
189
|
Stanton RC: Oxidative stress and diabetic
kidney disease. Curr Diab Rep. 11:330–336. 2011.PubMed/NCBI View Article : Google Scholar
|
|
190
|
Dronavalli S, Duka I and Bakris GL: The
pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol
Metab. 4:444–452. 2008.PubMed/NCBI View Article : Google Scholar
|
|
191
|
Goh SY and Cooper ME: Clinical review: The
role of advanced glycation end products in progression and
complications of diabetes. J Clin Endocrinol Metab. 93:1143–1152.
2008.PubMed/NCBI View Article : Google Scholar
|
|
192
|
Riser BL, Ladson-Wofford S, Sharba A,
Cortes P, Drake K, Guerin CJ, Yee J, Choi ME, Segarini PR and
Narins RG: TGF-β receptor expression and binding in rat mesangial
cells: Modulation by glucose and cyclic mechanical strain. Kidney
Int. 56:428–439. 1999.PubMed/NCBI View Article : Google Scholar
|
|
193
|
Kitada M, Ogura Y and Koya D: Rodent
models of diabetic nephropathy: Their utility and limitations. Int
J Nephrol Renovasc Dis. 9:279–290. 2016.PubMed/NCBI View Article : Google Scholar
|
|
194
|
Koya D, Hayashi K, Kitada M, Kashiwagi A,
Kikkawa R and Haneda M: Effects of antioxidants in diabetes-induced
oxidative stress in the glomeruli of diabetic rats. J Am Soc
Nephrol. 14 (Suppl 3):S250–S253. 2003.PubMed/NCBI View Article : Google Scholar
|
|
195
|
Lee EA, Seo JY, Jiang Z, Yu MR, Kwon MK,
Ha H and Lee HB: Reactive oxygen species mediate high
glucose-induced plasminogen activator inhibitor-1 up-regulation in
mesangial cells and in diabetic kidney. Kidney Int. 67:1762–1771.
2005.PubMed/NCBI View Article : Google Scholar
|
|
196
|
Huang JS, Chuang LY, Guh JY, Huang YJ and
Hsu MS: Antioxidants attenuate high glucose-induced hypertrophic
growth in renal tubular epithelial cells. Am J Physiol Renal
Physiol. 293:F1072–F1082. 2007.PubMed/NCBI View Article : Google Scholar
|
|
197
|
Huang JS, Chuang LY, Guh JY, Yang YL and
Hsu MS: Effect of taurine on advanced glycation end
products-induced hypertrophy in renal tubular epithelial cells.
Toxicol Appl Pharmacol. 233:220–226. 2008.PubMed/NCBI View Article : Google Scholar
|
|
198
|
Higo S, Miyata S, Jiang QY, Kitazawa R,
Kitazawa S and Kasuga M: Taurine administration after appearance of
proteinuria retards progression of diabetic nephropathy in rats.
Kobe J Med Sci. 54:E35–E45. 2008.PubMed/NCBI
|
|
199
|
Park SH, Choi HJ, Lee JH, Woo CH, Kim JH
and Han HJ: High glucose inhibits renal proximal tubule cell
proliferation and involves PKC, oxidative stress, and TGF-beta 1.
Kidney Int. 59:1695–1705. 2001.PubMed/NCBI View Article : Google Scholar
|
|
200
|
Huang JS, Chuang LY, Guh JY and Huang YJ:
Effects of nitric oxide and antioxidants on advanced glycation end
products-induced hypertrophic growth in human renal tubular cells.
Toxicol Sci. 111:109–119. 2009.PubMed/NCBI View Article : Google Scholar
|
|
201
|
Yao HT, Lin P, Chang YW, Chen CT, Chiang
MT, Chang L, Kuo YC, Tsai HT and Yeh TK: Effect of taurine
supplementation on cytochrome P450 2E1 and oxidative stress in the
liver and kidneys of rats with streptozotocin-induced diabetes.
Food Chem Toxicol. 47:1703–1709. 2009.PubMed/NCBI View Article : Google Scholar
|
|
202
|
Pandya KG, Budhram R, Clark GJ and Lau-Cam
CA: Taurine can enhance the protective actions of metformin against
diabetes-induced alterations adversely affecting renal function.
Adv Exp Med Biol. 803:227–250. 2015.PubMed/NCBI View Article : Google Scholar
|
|
203
|
Chen SW, Chen YX, Shi J, Lin Y and Xie WF:
The restorative effect of taurine on experimental nonalcoholic
steatohepatitis. Dig Dis Sci. 51:2225–2234. 2006.PubMed/NCBI View Article : Google Scholar
|
|
204
|
Miyazaki T, Karube M, Matsuzaki Y, Ikegami
T, Doy M, Tanaka N and Bouscarel B: Taurine inhibits oxidative
damage and prevents fibrosis in carbon tetrachloride-induced
hepatic fibrosis. J Hepatol. 43:117–125. 2005.PubMed/NCBI View Article : Google Scholar
|
|
205
|
Schlöndorff D: Choosing the right mouse
model for diabetic nephropathy. Kidney Int. 77:749–750.
2010.PubMed/NCBI View Article : Google Scholar
|
|
206
|
Perfumo F, Canepa A, Divino Filho JC,
Nilsson E, Carrea A, Verrina E, Gusmano R and Bergström J: Muscle
and plasma amino acids and nutritional status in
kidney-transplanted children. Nephrol Dial Transplant. 9:1778–1785.
1994.PubMed/NCBI
|
|
207
|
Wingenfeld P, Minor T, Gehrmann U,
Strübind S, Isselhard W and Michalk D: Hypoxic cellular
deterioration and its prevention by the amino acid taurine in a
transplantation model with renal tubular cells (LLC-PK1). In Vitro
Cell Dev Biol Anim. 31:483–486. 1995.PubMed/NCBI View Article : Google Scholar
|
|
208
|
Michalk DV, Hoffmann B and Minor Th:
Taurine Reduces Renal Ischemia/Reperfusion Injury in the Rat. In:
Taurine 5. Lombardini JB, Schaffer SW and Azuma J (eds). Springer,
Boston, MA, pp49-56, 2003.
|
|
209
|
Guz G, Oz E, Lortlar N, Ulusu NN, Nurlu N,
Demirogullari B, Omeroglu S, Sert S and Karasu C: The effect of
taurine on renal ischemia/reperfusion injury. Amino Acids.
32:405–411. 2007.PubMed/NCBI View Article : Google Scholar
|
|
210
|
Guan X, Dei-Anane G, Liang R, Gross ML,
Nickkholgh A, Kern M, Ludwig J, Zeier M, Büchler MW, Schmidt J, et
al: Donor preconditioning with taurine protects kidney grafts from
injury after experimental transplantation. J Surg Res. 146:127–134.
2008.PubMed/NCBI View Article : Google Scholar
|
